Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter

Welcome to the online edition of the Journal of Psychiatry and Neuroscience, the official journal of the Canadian College of Neuropsychopharmacology.

Psychopharmacology for the Clinician

Metformin for antipsychotic-induced metabolic disturbances

Written prescription for metformin

Latest Articles

  • Dexamphetamine widens temporal and spatial binding windows in healthy participants
    Increasing catecholamine release through the administration of dexamphetamine (0.45 mg/kg) increases temporal and spatial binding windows in the unimodal funnelling illusion.
  • Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
    Metformin is safe and effective for reducing antipsychotic-induced weight gain in individuals with intellectual and developmental disabilities.
  • We’re not in Kansas anymore: ectopic dopaminergic terminals as an explanation for the positive symptoms in psychiatric pathology
    Dopaminergic mistargeting may account, in part, for the presence of positive symptoms, and a reduction in terminals from intended targets may explain some of the negative symptoms and cognitive deficits observed in individuals with psychiatric disorders.
  • Action selection in early stages of psychosis: an active inference approach
    Active inference modelling of a probabilistic task may provide further explanation for dysfunctional mechanisms underlying decision-making in psychosis.
  • Thalamocortical functional connectivity in youth with attention-deficit/hyperactivity disorder
    Thalamocortical functional connectivity, based on the intrinsic network architecture of the brain, appears to be clinically relevant in ADHD.
More recent content  
  • Most Read
  • Most Cited
  • Responses
Loading
  • Why is depression more prevalent in women?
  • Brain cortical and subcortical morphology in adolescents with depression and a history of suicide attempt
  • Mindfulness-based treatments for posttraumatic stress disorder: a review of the treatment literature and neurobiological evidence
  • Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial
  • Hippocampal subfield alterations in schizophrenia and major depressive disorder: a systematic review and network meta-analysis of anatomic MRI studies
More...

Earn MOC credits
just by reading JPN!
Find out more

Back to top

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire